Cargando…
Inhibition of cancer cell growth by ruthenium complexes
BACKGROUND: Previous studies suggest that certain transition metal complexes, such as cisplatin, are efficacious for treating various cancer types, including ovarian, lung, and breast. METHODS: In order to further evaluate ruthenium (Ru) complexes as potential anti-cancer agents, we synthesized and...
Autores principales: | Iida, Joji, Bell-Loncella, Elisabeth T., Purazo, Marc L., Lu, Yifeng, Dorchak, Jesse, Clancy, Rebecca, Slavik, Julianna, Cutler, Mary Lou, Shriver, Craig D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751662/ https://www.ncbi.nlm.nih.gov/pubmed/26867596 http://dx.doi.org/10.1186/s12967-016-0797-9 |
Ejemplares similares
-
DNA Aptamers against Exon v10 of CD44 Inhibit Breast Cancer Cell Migration
por: Iida, Joji, et al.
Publicado: (2014) -
FH535 Inhibited Migration and Growth of Breast Cancer Cells
por: Iida, Joji, et al.
Publicado: (2012) -
Editorial of Special Issue Ruthenium Complex: The Expanding Chemistry of the Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2015) -
Special Issue on Ruthenium Complexes
por: Dragutan, Ileana, et al.
Publicado: (2017) -
Triaminocyclopentadienyl Ruthenium Complexes – New Catalysts for Cascade Conversions of Propargyl Alcohols
por: Hatzfeld, Jana, et al.
Publicado: (2021)